lobbying_activities: 2638986

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2638986	8f59bb4d-36cf-4daa-9fee-52c321e56a60	Q2	PUBLIC CITIZEN	32362	PUBLIC CITIZEN	2021	second_quarter	PHA	Covid-19 Vaccine Manufacturing and access and related funding, drug price negotiation, FAIR drug pricing Act, clinical trial cost transparency, HR 3 Lower drug prices now act, HR 2096-SACKLER Act, Affordable medications act, prescription drug price spike remedies, Medical Innovation act, National Biomedical research act, USTR access to medicines position, HR 3778/S 1976 (NOVID act), Aducanumab, S.1435-Affordable Prescriptions for Patients act,	Consumer Product Safety Commission (CPSC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Occupational Safety & Health Administration (OSHA),Securities & Exchange Commission (SEC),SENATE,Treasury, Dept of,White House Office		150000	0	0	2021-07-16T08:31:35.043000-04:00